Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Large B-Cell, Diffuse 2Fallopian Tube Neoplasms 2Uveal Melanoma 1Thymoma 1Solitary Fibrous Tumor, Pleural 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Unknown Primary 1Neoplasms, Plasma Cell 1Neoplasms 1Mesothelioma, Malignant 1Mediastinal Neoplasms 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Leukemia-Lymphoma, Adult T-Cell 1Leukemia, Myeloid, Acute 1Glioblastoma 1Eye Neoplasms 1Congenital Abnormalities 1Carcinoma, Ovarian Epithelial 1Carcinoma, Neuroendocrine 1Burkitt Lymphoma 1Brenner Tumor 1Bone Marrow Neoplasms 1

Interventions

fludarabine phosphate 47Peripheral Blood Stem Cell Transplantation 39Cyclophosphamide 39Busulfan 37Tacrolimus 33Mycophenolic Acid 29Methotrexate 26Cytarabine 25Cyclosporine 25Whole-Body Irradiation 24Antilymphocyte Serum 23Radiotherapy 16Etoposide 16Filgrastim 15Methylprednisolone 11Melphalan 11Transplantation 9Cord Blood Stem Cell Transplantation 9Idarubicin 8sargramostim 7Sirolimus 7Mitoxantrone 7merphos 6Thiotepa 6Granulocyte Colony-Stimulating Factor 6Flow Cytometry 6Alemtuzumab 6fludarabine 5aldesleukin 5Gemtuzumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Congenital Abnormalities × belinostat × Clear all
NCT00357032 2018-04-17

PXD101 in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
12 enrolled 6 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡